Tenaya Therapeutics Inc (NASDAQ:TNYA) shares, rose in value on Wednesday, April 16, with the stock price down by -8.97% to the previous day’s close as strong demand from buyers drove the stock to $0.46.
Actively observing the price movement in the last trading, the stock closed the session at $0.51, falling within a range of $0.4611 and $0.4995. The value of beta (5-year monthly) was 2.987. Referring to stock’s 52-week performance, its high was $4.96, and the low was $0.39. On the whole, TNYA has fluctuated by -32.36% over the past month.
With the market capitalization of Tenaya Therapeutics Inc currently standing at about $75.09 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-09.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TNYA’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of TNYA currently trading nearly -16.48% and -36.68% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 37.32, while the 7-day volatility ratio is showing 11.14% which for the 30-day chart, stands at 12.18%. Furthermore, Tenaya Therapeutics Inc (TNYA)’s beta value is 2.97, and its average true range (ATR) is 0.07.
A comparison of Tenaya Therapeutics Inc (TNYA) with its peers suggests the former has fared considerably weaker in the market. TNYA showed an intraday change of -8.97% in last session, and over the past year, it shrunk by -89.67%%.
Data on historical trading for Tenaya Therapeutics Inc (NASDAQ:TNYA) indicates that the trading volumes over the past 10 days have averaged 2.44 and over the past 3 months, they’ve averaged 3.38 million. According to company’s latest data on outstanding shares, there are 162.58 million shares outstanding.
Nearly 17.52% of Tenaya Therapeutics Inc’s shares belong to company insiders and institutional investors own 20.39% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 10.82 million shares as on 2025-03-31, resulting in a short ratio of 1.88. According to the data, the short interest in Tenaya Therapeutics Inc (TNYA) stood at 780.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 14.4 million. The stock has fallen by -67.70% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TNYA stock heading into the next quarter.
